8/5/2023 0 Comments Quit smoking aids inhaler![]() ![]() A Cochrane review has compared the efficacy of drugs that support quitting for six months or longer (Table). They are available on the Pharmaceutical Benefits Scheme (PBS), as long as they are part of a comprehensive treatment plan for smoking cessation. There are three approved drug therapies in Australia – varenicline, bupropion and nicotine replacement therapy. ![]() Most current smokers are likely to be significantly nicotine dependent ( Box 2), so it is appropriate to consider drug therapy to help them quit. Smokers who are not physiologically dependent on nicotine and are ready to quit are more likely to respond to behavioural interventions than dependent patients. National Cannabis Prevention and Information Centre Supporting smoking cessation: a guide for health professionals Royal Australian College of General Practitioners Stop smoking – what works for your patients?Īustralian Association of Smoking Cessation Professionals This site provides access to the ‘Quit for New Life’ program which especially targets Aboriginal mothers.Īboriginal and Torres Strait Islander information – Go to the tab ‘Information’ select ‘Factsheets and podcasts’, under ‘Mind & body’ select ‘Smoking and mental illness’ (patient information sheet). – Go to the tab ‘I want info on’ and then ‘Mental illness and quitting’ (health professionals and patient information sheets). Common risks for lapse or relapse include stressful circumstances, consuming alcohol and being with friends or family who smoke. The management focus is to help prevent relapse and to continue being supportive when relapse occurs, providing encouragement for further attempts to quit in the future. It is essential that both doctor and patient persevere in managing nicotine addiction regardless of apparently entrenched negative beliefs or the number of previous attempts to quit. Recent evidence suggests some smoking cessation programs that also provide financial incentives for participants can be highly effective. 6 - 10 Smoking cessation is more likely to succeed when the smoker is motivated to quit, hence skill in motivational interviewing is additionally helpful for the practitioner. Cognitive and behavioural interventions, such as motivational interviewing and relapse prevention, are an essential adjunct to the efficacy of these drugs. 5, 11, 12 These drugs are most effective when used in conjunction with behavioural therapies and support ( Box 1). 6 - 10 There is also emerging evidence about tailoring interventions to individuals in a personalised medicine approach. There is a lot of evidence regarding the efficacy of the drugs used in smoking cessation. ![]() A number of excellent recent reviews on smoking cessation are available. Commonly, people who recover from addiction appear to learn how to manage lapses and relapses, largely from their experience of multiple cycles of lapse (‘slip up’) and relapse (reinstatement of dependence). 3 - 5 Nonetheless, most smokers eventually consider quitting, so few smokers are completely resistant to interventions to stop smoking. A higher proportion now have more severe forms of nicotine addiction and comorbidity. 2įollowing the decline in smoking prevalence in Australia, the profile of smokers has changed. ![]() In 2001, 22.4% of the population aged 18 or over smoked, while by 2011–12 this rate had reduced to 16.4%. 1 However nicotine addiction is declining in Australia, indicating that for some smokers remission after quitting may be long lasting. This addiction is a chronic disease state that is prone to relapses and remissions. Most tobacco smokers are addicted to nicotine. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |